Rallybio Corporation (RLYB)
USD 0.98
(-5.22%)
USD 0.98
(-5.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -60.26 Million | -57.28 Million | -45.53 Million | -22.03 Million | -15.02 Million |
| Net Income | -74.56 Million | -66.65 Million | -47.01 Million | -26.44 Million | -17.56 Million |
| Depreciation & Amortization | 150 Thousand | 167 Thousand | 109 Thousand | 62 Thousand | 26 Thousand |
| Deferred income taxes | 99 Thousand | - | - | - | 103 Thousand |
| Stock-based compensation | 10.92 Million | 9.49 Million | 3.64 Million | 704 Thousand | 194 Thousand |
| Change in working capital | 4.27 Million | -936 Thousand | -3.77 Million | 2.12 Million | 2.07 Million |
| Other non-cash items | -1.14 Million | 640 Thousand | 1.5 Million | 1.52 Million | 144 Thousand |
| Investing Cash Flow | 27.65 Million | -112.17 Million | -2.33 Million | -2.07 Million | -188 Thousand |
| Investments in PPE | -12 Thousand | -54 Thousand | -333 Thousand | -137 Thousand | -188 Thousand |
| Acquisitions | -2.25 Million | -300 Thousand | -2 Million | -1.93 Million | - |
| Investment purchases | -110.66 Million | -201.31 Million | -2 Million | -1.93 Million | - |
| Sales/Maturities of investments | 138.33 Million | 89.5 Million | 2 Million | 1.93 Million | - |
| Other Investing Activities | 2.25 Million | -112.11 Thousand | -2000.00 | -1935.00 | - |
| Financing Cash Flow | 143 Thousand | 51.07 Million | 82.96 Million | 144.88 Million | 31.56 Million |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | 282 Thousand | 217 Thousand | - | - | - |
| Common Stock Issuance | 143 Thousand | 51.07 Million | 86.2 Million | 145.2 Million | 31.6 Million |
| Other Financing Activities | -139 Thousand | -693 Thousand | -3.23 Million | -319 Thousand | -33 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -99 Thousand | 487 Thousand | -976 Thousand | 723 Thousand | 728 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 4.37 Million | -1.42 Million | -2.8 Million | 1.39 Million | 1.34 Million |
| Cash at beginning of period | 56.95 Million | 175.33 Million | 140.23 Million | 19.45 Million | 3.1 Million |
| Cash at end of period | 24.49 Million | 56.95 Million | 175.33 Million | 140.23 Million | 19.45 Million |
| Capital Expenditure | -12 Thousand | -54 Thousand | -333 Thousand | -137 Thousand | -188 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -32.46 Million | -118.37 Million | 35.1 Million | 120.77 Million | 16.35 Million |
| Free Cash Flow | -60.27 Million | -57.33 Million | -45.86 Million | -22.17 Million | -15.21 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.23 Million | -19.02 Million | -74.56 Million | -20.24 Million | -18.37 Million | -18.63 Million |
| Depreciation & Amortization | 34 Thousand | 35 Thousand | 150 Thousand | 36 Thousand | 37 Thousand | 38 Thousand |
| Deferred income taxes | - | - | 99 Thousand | -2.09 Million | 648 Thousand | 217 Thousand |
| Stock-based compensation | 1.91 Million | 2.08 Million | 10.92 Million | 2.54 Million | 2.63 Million | 2.69 Million |
| Change in working capital | 3.79 Million | 1.3 Million | 4.27 Million | 6.05 Million | -713 Thousand | 3.13 Million |
| Other non-cash items | 1.3 Million | 2.81 Million | -1.14 Million | 2.05 Million | -703 Thousand | -834 Thousand |
| Investing Cash Flow | 2.59 Million | 10.26 Million | 27.65 Million | 16.9 Million | 3.07 Million | 6.21 Million |
| Investments in PPE | - | - | -12 Thousand | -12 Thousand | -3070.00 | - |
| Acquisitions | -750 Thousand | -750 Thousand | -2.25 Million | -750 Thousand | -750 Thousand | - |
| Investment purchases | -19.9 Million | -11.48 Million | -110.66 Million | -13.48 Million | -34.07 Million | -32.31 Million |
| Sales/Maturities of investments | 22.5 Million | 21.75 Million | 138.33 Million | 30.41 Million | 37.89 Million | 38.53 Million |
| Other Investing Activities | 2596.00 | -750 Thousand | 2.25 Million | 750 Thousand | 3070.00 | 6214.00 |
| Financing Cash Flow | 5.19 Million | - | 143 Thousand | 72 Thousand | - | 210 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 282 Thousand | 282 Thousand | - | - |
| Common Stock Issuance | 5.19 Million | - | 143 Thousand | 72 Thousand | - | 210 Thousand |
| Other Financing Activities | 5192.00 | - | -139 Thousand | -1000.00 | - | 1000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 748 Thousand | -506 Thousand | -99 Thousand | 524 Thousand | -236 Thousand | -92 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.05 Million | 1.8 Million | 4.37 Million | 5.53 Million | -477 Thousand | 3.22 Million |
| Cash at beginning of period | 19.3 Million | 24.49 Million | 56.95 Million | 19.15 Million | 32.55 Million | 39.51 Million |
| Cash at end of period | 16.67 Million | 19.3 Million | 24.49 Million | 24.49 Million | 19.15 Million | 32.55 Million |
| Capital Expenditure | - | - | -12 Thousand | -12 Thousand | -3070.00 | - |
| Effect of forex changes on cash | - | - | - | 28.98 Million | - | -28.98 Million |
| Net cash flow / Change in cash | -2.63 Million | -5.19 Million | -32.46 Million | 5.33 Million | -13.4 Million | -6.96 Million |
| Free Cash Flow | -10.41 Million | -15.45 Million | -60.27 Million | -11.65 Million | -16.47 Million | -13.38 Million |
PBCRY
7865
TITA-B
GDR
4421
ACE